Oral administration of SVP in T2DM mice also could improve the diabetic complications of hyperlipidemia and inflammation response, indicating as lower concentrations of TC, TG, LDL-c, FFA, TBA, TNF-α, IL-6, and higher levels of IL-10 in serum. Here, TNF is linked to type 2 diabetes mellitus.